Crysis 2

Aliens are decimating New York City, only you have the technology to survive. Be The Weapon.

₦20,000 ₦800
Excluding Tax
Cheapest shipping from ₦2,000.95
Stock Status: 12 pcs
Delivery Status: 1

pcs

Crysis 2


On August 23, 2023, a United States Marine Corps Force Recon unit is deployed into New York City by the submarine USS Nautilus to extract former Crynet employee Doctor Nathan Gould, who may have vital information on combating the alien race. However, insertion goes awry - the Ceph, the alien race that is trying to destroy humanity, sinks the sub, mortally wounding Force Recon Marine "Alcatraz." Delta Force Major Laurence "Prophet" Barnes saves Alcatraz and is forced to kill himself in order for his Nanosuit to assimilate and revive Alcatraz. A recording left in the suit reveals that Prophet had been infected by the Manhattan virus, and that Alcatraz is to finish Prophet's mission to rescue humanity from the alien invasion. Believing Alcatraz is Prophet, Gould soon gets in contact with Alcatraz and asks him to meet up at Gould's lab. However, CELL forces, led by Commander Dominic Lockhart, target and attack Alcatraz, believing him to be Prophet. While on his way to Gould's laboratory, Alcatraz collects alien tissue samples from a crashed Ceph dropship and a Ceph soldier, which cause strange reactions within his Nanosuit, giving him some alien abilities. Alcatraz eventually meets with Gould, who is initially hostile after learning that he is not Prophet. However the last suit recording of Prophet's message causes Gould to relent, prompting Gould to explain that the suit has been busy rewriting its own code after absorbing the Ceph's tissue, speculating that the suit was creating an antibody for the Manhattan virus. Gould and Alcatraz commit to further scans at a Crynet base on Wall Street. The scans are cut short when CELL forces led by Commander Lockhart and Lieutenant Tara Strickland, daughter of U.S. Marine Corps Major Strickland

We rely on cookies to provide our services. By using our services, you agree to our use of cookies.